(Q30962846)

English

Monoclonal antibodies in man that neutralized H3N2 influenza viruses were classified into three groups with distinct strain specificity: 1968-1973, 1977-1993 and 1997-2003.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

Monoclonal antibodies in man that neutralized H3N2 influenza viruses were classified into three groups with distinct strain specificity: 1968-1973, 1977-1993 and 1997-2003. (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

1 reference

based on heuristic

inferred from title

author name string

Jun Okada

1

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

Nobuko Ohshima

2

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

Ritsuko Kubota-Koketsu

3

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

Sayuri Ota

4

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

Wakana Takase

5

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

Masachika Azuma

6

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

Yoshitaka Iba

7

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

Naoko Nakagawa

8

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

Tetsushi Yoshikawa

9

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

Youichi Nakajima

10

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

Toyokazu Ishikawa

11

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

Yoshizo Asano

12

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

Yoshinobu Okuno

13

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

Yoshikazu Kurosawa

14

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

language of work or name

0 references

publication date

6 December 2009

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

397

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

322-330

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

High-level expression of a recombinant antibody from myeloma cells using a glutamine synthetase gene as an amplifiable selectable marker

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.11.025

7 January 2021

Characterization of a novel influenza A virus hemagglutinin subtype (H16) obtained from black-headed gulls

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.11.025

7 January 2021

Role of the B-cell response in recovery of mice from primary influenza virus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.11.025

7 January 2021

Original and artificial antibodies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.11.025

7 January 2021

The evolution of human influenza viruses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.11.025

7 January 2021

Expression vectors for the introduction of highly diverged sequences into the six complementarity-determining regions of an antibody

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.11.025

7 January 2021

By-passing immunization. Human antibodies from V-gene libraries displayed on phage

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.11.025

7 January 2021

Antibody fusions with fluorescent proteins: a versatile reagent for profiling protein expression.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.11.025

7 January 2021

Antigenic variants with amino acid deletions clarify a neutralizing epitope specific for influenza B virus Victoria group strains

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.11.025

7 January 2021

Neutralizing epitopes specific for influenza B virus Yamagata group strains are in the 'loop'.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.11.025

7 January 2021

Influenza: old and new threats

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.11.025

7 January 2021

Mapping of Antigenic Changes in the Haemagglutinin of Hong Kong Influenza (H3N2) Strains using a Large Panel of Monoclonal Antibodies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.11.025

7 January 2021

A fairly conserved epitope on the hemagglutinin of influenza A (H3N2) virus with variable accessibility to neutralizing antibody

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.11.025

7 January 2021

Structural identification of the antibody-binding sites of Hong Kong influenza haemagglutinin and their involvement in antigenic variation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.11.025

7 January 2021

Making antibodies by phage display technology

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.11.025

7 January 2021

Virus-neutralizing antibodies of immunoglobulin G (IgG) but not of IgM or IgA isotypes can cure influenza virus pneumonia in SCID mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.11.025

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VIROL.2009.11.025

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q30962846&oldid=1980224437"